Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity - Additional Information (Details)

v3.25.1
Stockholders' Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Nov. 30, 2024
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Jun. 03, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Net proceeds from offering     $ 0 $ 16,183    
Common stock, shares issued (in shares)     27,980,184   27,617,415  
Employee Stock Purchase Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares available for grant (in shares)     138,998     400,000
Offering period     6 months      
Public Offering            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Public offering (in shares)   2,653,848        
Common stock initially offered at public offering (in shares)   2,307,694        
Sale of stock, price per share (in usd per share)   $ 6.5   $ 6.5    
Shares sold pursuant to exercise of underwriters option (in shares)   346,154        
Net proceeds from offering   $ 16,200        
At-The-Market Equity Offering            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Sale of stock maximum proceeds on potential common stock offering $ 50,000          
Common stock, shares issued (in shares)     0